REPEVAX, suspension for injection, in pre-filled syringe Diphtheria, Tetanus, Pertussis (acellular, component) and Poliomyelitis (inactivated) Vaccine (adsorbed, reduced antigen(s) content) Ireland - English - HPRA (Health Products Regulatory Authority)

repevax, suspension for injection, in pre-filled syringe diphtheria, tetanus, pertussis (acellular, component) and poliomyelitis (inactivated) vaccine (adsorbed, reduced antigen(s) content)

sanofi pasteur - tetanus toxoid; diphtheria toxoid; pertussis toxoid; filamentous haemagglutinin (fha); pertactin; polio virus type 1 inactivated; polio virus type 2 inactivated; polio virus type 3 inactivated; adsorbed aluminium phosphate; adsorbed fimbriae types 2 + 3 - suspension for injection in pre-filled syringe - 0.5 millilitre(s) - bacterial and viral vaccines, combined; diphtheria-pertussis-poliomyelitis-tetanus

REVAXIS Suspension for injection in pre-filled syringe Diphtheria, tetanus and poliomyelitis (inactivated) vaccine (adsorbed, reduced antigen(s) content) Ireland - English - HPRA (Health Products Regulatory Authority)

revaxis suspension for injection in pre-filled syringe diphtheria, tetanus and poliomyelitis (inactivated) vaccine (adsorbed, reduced antigen(s) content)

sanofi pasteur - diphtheria toxoid; tetanus toxoid; poliovirus, type 1; poliovirus, type 2; poliovirus, type 3 - suspension for injection in pre-filled syringe - 0.5 millilitre(s) - bacterial and viral vaccines, combined; diphtheria-poliomyelitis-tetanus

ADACEL POLIO pertussis vaccine - acellular, diphtheria and tetanus toxoids (adsorbed) combined with inactivated poliovirus 0.5mL Australia - English - Department of Health (Therapeutic Goods Administration)

adacel polio pertussis vaccine - acellular, diphtheria and tetanus toxoids (adsorbed) combined with inactivated poliovirus 0.5ml

sanofi-aventis australia pty ltd - diphtheria toxoid,pertactin,pertussis filamentous haemagglutinin,pertussis fimbriae 2 + 3,pertussis toxoid,poliovirus,tetanus toxoid -

Boostrix Polio inj. susp. i.m. pre-filled syr. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

boostrix polio inj. susp. i.m. pre-filled syr.

glaxosmithkline biologicals sa-nv - bordetella pertussis filamentous hemagglutinin (fha) 8 µg/dose; diphtheria toxoid (dt) >= 2 iu/dose; poliovirus type 3 (inactivated) 32 d-antigen u/1 dose; pertactin (bordetella pertussis antigen) 2,5 µg/dose; bordetella pertussis toxoid (pt) 8 µg/dose; tetanus toxoid >= 20 iu/dose; poliovirus type 2 (inactivated) 8 d-antigen u/1 dose; poliovirus type 1 (inactivated) 40 d-antigen u/1 dose - suspension for injection in pre-filled syringe - diphteria toxoid, adsorbed; poliomyelitis virus, inactivated; tetanus toxoid adsorbed; bordetella pertussis antigen, proteins - diphtheria-pertussis-poliomyelitis-tetanus

Boostrix Polio inj. susp. i.m. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

boostrix polio inj. susp. i.m. vial

glaxosmithkline biologicals sa-nv - bordetella pertussis filamentous hemagglutinin (fha) 8 µg/dose; diphtheria toxoid (dt) >= 2 iu/dose; poliovirus type 3 (inactivated) 32 d-antigen u/1 dose; pertactin (bordetella pertussis antigen) 2,5 µg/dose; bordetella pertussis toxoid (pt) 8 µg/dose; tetanus toxoid >= 20 iu/dose; poliovirus type 2 (inactivated) 8 d-antigen u/1 dose; poliovirus type 1 (inactivated) 40 d-antigen u/1 dose - suspension for injection - diphteria antigen, adsorbed; poliomyelitis virus; tetanus toxoid adsorbed; bordetella pertussis antigen, proteins - diphtheria-pertussis-poliomyelitis-tetanus

Triaxis Polio 0.5 ml inj. susp. i.m. pre-filled syr. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

triaxis polio 0.5 ml inj. susp. i.m. pre-filled syr.

sanofi pasteur europe s.a. - bordetella pertussis filamentous hemagglutinin (fha) 5 µg/dose; poliovirus type 1 (inactivated) 40 d-antigen u/1 dose; poliovirus type 3 (inactivated) 32 d-antigen u/1 dose; bordetella pertussis pertactin 3 µg/dose; bordetella pertussis toxoid (pt) 2,5 µg/dose; bordetella pertussis purified fimbrial agglutinogens 2 and 3 (fim) 5 µg/dose; diphtheria toxoid (dt) 2 ; poliovirus type 2 (inactivated) 8 d-antigen u/1 dose; tetanus toxoid 20 - suspension for injection - 0,5 ml - diphteria antigen, adsorbed; poliomyelitis virus; tetanus toxoid adsorbed; bordetella pertussis antigen, proteins - diphtheria-pertussis-poliomyelitis-tetanus

Inactivated Poliomyelitis Vaccine Namibia - English - Namibia Medicines Regulatory Council

inactivated poliomyelitis vaccine

bilhoven biological - poliomyelitis vaccine - vaccine - one human dose of 0.5 ml ipv contains - inacticated poliomyelitis virus type 1-40 d-antigen units; inactivated poliomyelitis vir

Imovax Polio Namibia - English - Namibia Medicines Regulatory Council

imovax polio

sanofi-aventis sa (pty) ltd - polio virus type 1, polio virus type 2 and polio virus type 3 - injection - each 0,5 ml dose contains; polio virus type 1 40.0 antigent d units, polio virus type 2 8,0 antigent d units and polio virus typ

Oral Polio Vaccine Trivalent Namibia - English - Namibia Medicines Regulatory Council

oral polio vaccine trivalent

serum institute of india limited - polio virus (sabin) type 1 , polio virus (sabin) type 2, polio virus (sabin) type 3 - oral vaccine - each dose of 2 drops contains polio virus (sabin) type 1 > 10 6.1 ccid50, polio virus (sabin) type 2 > 10 5.0 ccid50, polio viru

Poliovac 0.5 mL Suspension For Injection (IM/SC) Philippines - English - FDA (Food And Drug Administration)

poliovac 0.5 ml suspension for injection (im/sc)

n/a; importer: faberco life sciences inc.; distributor: faberco life sciences inc. - inactivated poliomyelitis vaccine (types 1, 2 and 3) - suspension for injection (im/sc) - 0.5 ml